What is idiopathic intracranial hypertension (IIH) in obese women of childbearing age?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: January 21, 2026View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

What is Pseudotumor Cerebri (Idiopathic Intracranial Hypertension)?

Pseudotumor cerebri, also known as idiopathic intracranial hypertension (IIH), is a syndrome of elevated intracranial pressure without an identifiable structural cause that most commonly affects obese women of childbearing age and can lead to permanent vision loss if untreated. 1, 2

Definition and Terminology

  • Pseudotumor cerebri and idiopathic intracranial hypertension are interchangeable terms referring to the same clinical condition 2
  • Primary pseudotumor cerebri syndrome (PTCS) is specifically known as idiopathic intracranial hypertension 1, 2
  • This is a diagnosis of exclusion—other causes of increased intracranial pressure must be ruled out before confirming IIH 3

Who Gets This Condition?

The typical patient is an obese woman of childbearing age, but important exceptions exist 1, 4:

  • Most commonly affects overweight females of childbearing age 1, 2
  • Can also occur in obese males and prepubertal thin girls and boys 1, 2
  • In prepubertal children, boys and girls are equally affected, unlike the female predominance seen after puberty 1
  • The incidence is rising in parallel with the obesity epidemic 1, 2

Clinical Presentation

Patients typically present with severe headaches and visual disturbances, though the symptom profile can be highly variable 1, 5:

  • Headache is the most common presenting symptom—progressively more severe and frequent, with a phenotype that may mimic other primary headache disorders 5
  • Transient visual obscurations (unilateral or bilateral darkening of vision lasting seconds) are characteristic 5
  • Pulsatile tinnitus (whooshing sound synchronous with pulse) 5
  • Visual blurring 5
  • Papilledema is the hallmark finding and should be documented 5
  • Sixth nerve palsy may be present, but involvement of other cranial nerves should prompt consideration of alternative diagnoses 1, 5

Important caveat: None of these symptoms are pathognomonic for IIH—they can occur in other conditions, making diagnosis challenging 5

Pathophysiology

The exact cause remains unclear, but proposed mechanisms include 1, 2:

  • Impaired cerebrospinal fluid (CSF) homeostasis 2
  • Altered venous hemodynamics 2
  • Reduced cerebral drainage through the internal jugular vein 2
  • Increased intracranial CSF volume accumulating in the subarachnoid space 2

Diagnostic Criteria

To diagnose IIH, you must demonstrate elevated intracranial pressure while excluding structural causes 1, 2:

  • Papilledema (typically present but not always required) 2
  • Normal neurological examination (except possible sixth nerve palsy) 1, 2
  • Normal brain parenchyma on imaging—no mass, hydrocephalus, or abnormal meningeal enhancement 1, 2
  • Normal cerebrospinal fluid composition 1, 2
  • Elevated lumbar puncture opening pressure: ≥25 cm H₂O (≥250 mm H₂O) measured in the lateral decubitus position 5
    • In children: >280 mm CSF (or >250 mm CSF if not sedated and not obese) 1, 2

Critical measurement technique: The patient must be in lateral decubitus position, relaxed, with legs extended and breathing normally, with measurement taken after pressure stabilizes 5

Imaging Findings

MRI is the preferred imaging modality and may show secondary signs of increased intracranial pressure 1:

  • Empty sella 1, 2
  • Dilated optic sheaths (mean size 4.3 mm in IIH versus 3.2 mm in controls) 5, 2
  • Tortuous or enhancing optic nerves 1, 2
  • Flattening of the posterior aspects of the globes (56% sensitivity, 100% specificity) 5, 2
  • Intraocular protrusion of the optic nerve (40% sensitivity, 100% specificity) 5
  • Transverse sinus stenosis 2
  • Smaller pituitary gland size (mean 3.63 mm in IIH versus 5.05 mm in controls) 5

MRI provides superior soft tissue contrast compared to CT and is particularly valuable in pediatric patients 5

Secondary Causes to Exclude

Secondary pseudotumor cerebri can result from 1, 2:

  • Cerebral venous abnormalities such as thrombosis (CT or MR venography is mandatory within 24 hours) 1, 5
  • Medications: vitamin A, retinoids, tetracyclines, steroids, growth hormone, thyroxine, lithium 1, 2
  • Endocrine disorders: Addison disease, hypoparathyroidism 1, 2

In non-obese prepubertal children, cerebral venous sinus thrombosis should be particularly considered, making venography especially important in this population 5

Most Serious Consequence

The most serious long-term consequence is permanent vision loss from untreated papilledema leading to optic atrophy 6, 3. This makes ophthalmologic monitoring essential in all IIH patients 7, 6.

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Guideline

Idiopathic Intracranial Hypertension

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Research

Idiopathic Intracranial Hypertension.

Continuum (Minneapolis, Minn.), 2019

Guideline

Diagnosing Idiopathic Intracranial Hypertension (IIH)

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2026

Guideline

Treatment of Pseudotumor Cerebri (Idiopathic Intracranial Hypertension)

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Related Questions

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.